Healthcare stocks were trading with losses, with the S&P BSE Healthcare index decreasing 215.68 points or 0.86% at 24954.37 at 13:50 IST.
Among the components of the S&P BSE Healthcare index, Nectar Lifescience Ltd (down 7.56%), Venus Remedies Ltd (down 4.66%),Sequent Scientific Ltd (down 4.21%),Dishman Carbogen Amcis Ltd (down 3.78%),Vimta Labs Ltd (down 3.33%), were the top losers. Among the other losers were Solara Active Pharma Sciences Ltd (down 3.26%), Glaxosmithkline Pharmaceuticals Ltd (down 3.18%), Biocon Ltd (down 2.98%), Narayana Hrudayalaya Ltd (down 2.95%), and Strides Pharma Science Ltd (down 2.68%).
On the other hand, Lasa Supergenerics Ltd (up 10.84%), Medicamen Biotech Ltd (up 9.95%), and Kopran Ltd (up 4.99%) turned up.
At 13:50 IST, the S&P BSE Sensex was up 176.91 or 0.31% at 57964.94.
The Nifty 50 index was up 43.55 points or 0.25% at 17264.95.
The S&P BSE Small-Cap index was down 154.47 points or 0.53% at 29090.36.
The S&P BSE 150 Midcap Index index was down 51.23 points or 0.58% at 8829.72.
On BSE,1437 shares were trading in green, 1852 were trading in red and 104 were unchanged.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
